3 reports

  • Mar 22, 2017: AC Immune Provides Twelve Updates on its Pipeline at the International Conference on Alzheimer's And Parkinson's Diseases
  • Section 5 - Company's Recent Developments

The recently identified mechanism of spreading of the alpha-synuclein pathology in neurodegenerative diseases make alpha-synuclein a target for this antibody program.

  • Dementia
  • Pathology
  • World
  • Company Financials
  • AC Immune SA
  • Aug 22, 2017: AC Immune Discovers Next-generation Antibodies Focused On Neurodegenerative Diseases
  • Government and Public Interest

The support of MJFF further validates AC Immune' s leading expertise in the pathology of misfolded proteins.

  • Pathology
  • Pharmaceutical
  • United States
  • Product Initiative
  • AC Immune SA

Under the terms of the agreement AC Immune will provide its expertise in the biology and pathology of Tau as well as committing its laboratory capabilities to support the collaborative research program.

  • Pathology
  • Switzerland
  • United States
  • Product Initiative
  • AC Immune SA